• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.10% Nasdaq Down 1.82%

    Ligand Pharmaceuticals Incorporated (LGND)

    -NasdaqGM
    88.79 Down 3.71(4.01%) 4:00PM EST
    |After Hours : 88.81 Up 0.02 (0.02%) 4:59PM EST
    Prev Close:92.50
    Open:91.09
    Bid:88.75 x 300
    Ask:108.70 x 200
    1y Target Est:122.50
    Beta:0.908519
    Next Earnings Date:10-Feb-16LGND Earnings announcement
    Day's Range:87.27 - 93.32
    52wk Range:53.53 - 114.00
    Volume:564,106
    Avg Vol (3m):387,794
    Market Cap:1.77B
    P/E (ttm):7.31
    EPS (ttm):12.15
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for LGND

    Comparison

    Symbol% ChgMkt Cap
    LGNDDown 4.01%1.77B
    MRKDown 1.11%136.41B
    LLYDown 0.17%78.57B

    Key Statistics

    Forward P/E (1 yr):26.04
    P/S (ttm):25.00
    Ex-Dividend Date:02-Jul-10

    Analysts

    Annual EPS Est (Dec-15) :3.36
    Quarterly EPS Est (Dec-15) :0.65
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):0.63

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Ligand Pharmaceuticals Incorporated operates as a biotechnology company in the United States. The company’s commercial programs include Promacta, an oral medicine that increases the number of platelets in the blood; Kyprolis that is used for ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback